Ignite Creation Date:
2024-05-06 @ 4:15 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04920019
Status:
COMPLETED
Last Update Posted:
2023-08-23
First Post:
2021-05-21
Brief Title:
Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery
Sponsor:
Mahidol University
Organization:
Mahidol University
Study Overview
Official Title:
Opioid Sparing Effect of Thoracic Epidural Analgesia for Open Upper Abdominal Surgery Prospective Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prospective randomized controlled study is aimed to determine the advantages of thoracic epidural analgesia for open upper abdominal surgery in combination with multimodal analgesia compared with no thoracic epidural analgesia on postoperative pain control The primary outcome is total opioid consumption in postoperative 72 hours Secondary outcomes are the success of continuous epidural analgesia or complications of this technique pain intensity morbidity and mortality compare to no continuous epidural analgesia
Detailed Description:
Continuous epidural analgesia CEA for open upper abdominal surgery has been showed the analgesic analgesia for open abdominal surgery However the technical difficulty complications especially hypotension pruritus of CEA impede the popularity of technique compared to intravenous patient-controlled analgesia IV PCA in multimodal analgesia This study is aimed to study of the role of CEA and multimodal analgesia in open abdominal surgery compare to IV PCA
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None